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ABSTRACT 
Objective: Based on obtaining germacrene A, which is the analogue of synthetic β-elemene, by means of synthetic biology，this experiment 
aims to explore the anti-tumor effect of germacrene A.  
Methods: The cell line used in this study was bladder cancer T24 cells. The morphological changes of bladder cancer T24 cells treated with 
germacrene A were observed by inverted microscope; the death of cancer cells was observed by trypan blue staining; cell viability was 
measured by the MTT assay and the inhibition rate of the cancer cells by the germacrene A was investigated. Based on the results obtained 
from the experiments, the anti-cancer effect of germacrene A derived from synthetic biology was analyzed. 
Results: After administration, the volume of T24 cells was significantly reduced. The shape of the T24 cells gradually changed from 
wedge-shaped and polygonal to round, and the T24 cells soon fell off, atrophied and disintegrated. After Tet blue staining, a large number of 
T24 cells after administration were observed to be dead; It was found by means of MTT assay that T24 cells were inhibited to varying 
degrees by the effects of different concentrations of germacrene A.  
Conclusion: The above experimental results show that the synthetic biological source of germacrene A has obvious inhibitory effect on 
bladder cancer T24 cells, and this effect has obvious time and concentration dependence. 
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1 INTRODUCTION 
1.1 Research status and significance 
According to a global survey of cancer by scientists, the 
incidence of cancer has continued to rise in recent years, 
and new cancer cases in China are at the forefront. 
Bladder cancer is a malignant tumor that occurs on the 
bladder mucosa. It is the most common malignant tumor 
in the urinary system and one of the top ten common 
tumors in the body. It accounts for the first incidence of 
urogenital tumors in China. Bladder cancer has a high 
mortality rate as a common tumor in the urinary system, 
and its main cause of death is postoperative recurrence. 
It ranks fourth among common malignant tumors in the 
United States and ninth in the genitourinary system 
worldwide. Although the treatment of other cancers is 
progressing rapidly, the treatment of bladder cancer is 
relatively stagnant. The treatment of superficial bladder 
cancer includes a thorough transurethral resection of 
bladder tumor plus postoperative intravesical instillation 
of BCG, bladder infusion chemotherapy drug epirubicin, 
pirarubicin, intravesical chemotherapy and immune 
therapy, etc. But it is always difficult to remove all 
lesions and does not solve the problem of high 
recurrence after surgery and progressing to a higher 
level. Therefore, identifying new treatments and 
improving response to existing treatments may help 
improve the prognosis of patients with bladder cancer. 
The national second-class anticancer drug, elemene, is 
an effective anti-cancer ingredient extracted from 
sputum, with mild side effects, clear curative effect, and 
many advantages 
1
. And its anti-cancer effect is better 
than some traditional chemotherapy drugs, and elemene 
shows low toxicity to normal cells
2
. 
This kind of anticancer drug mainly comes from natural 
plant extraction, but the direct extraction production 
method has many uncontroll abilities and shortcomings. 
Therefore, finding a new mode of production has 
become an inevitable trend. 
In recent years, many researchers have developed new 
ways, such as the introduction of dehydrogenase and 
cytochrome P450 enzymes derived from Artemisia 
annua plants, so that the production of artemisinin can 
increase to industrial level
 3
. This idea of producing 
natural medicines through synthetic biology has been 
recognized by the scientific community.  
1.2 β-elemene 
Elemene is a kind of non-cytotoxic anti-tumor drug 
extracted from natural plant Wenyujin, which has 
inhibitory effects on various tumor cells. The most 
important active ingredient is β-elemene. The chemical 
name of β-elemene is 1-methyl-1-vinyl-2,4-diisopropyl 
cyclohexane, and its molecular formula is C15H24. The 
molecular weight of β-elemene is 204 4, β-elemene 
mainly exerts direct anti-tumor effects by inhibiting 
tumor cell proliferation, inducing apoptosis of tumor 
cells and inhibiting angiogenesis in tumor tissues, and it 
also can inhibit distant metastasis of tumors, and exert 
direct or indirect resistance. Meanwhile，β-elemene can 
be used in a variety of cancers in clinical applications. 
As an effective ingredient in the extraction of pure 
natural Chinese herbal medicines, β-elemene has 
excellent properties such as abundant sources and less 
toxic side effects, and it has broad prospects in 
anti-tumor therapy. 
According to the current research results, β-elemene is 
mainly played by inhibiting tumor cell migration and 
invasion 
5-7
, inducing tumor cell apoptosis 
8-9 
and 
inhibiting tumor angiogenesis 
10
. It has broad prospects 
for use in clinical treatment. 
1.3 Synthetic biology 
Synthetic biology, as a discipline of biology and 
engineering, is actually the application of engineering 
thinking in biology
 11
. Most of the plant-derived natural 
drugs are synthesized by the organism itself, and they 
are a trace amount of secondary metabolites, such as, 
artemisinin, glycyrrhizic acid, morphine, asiaticoside, 
paclitaxel, and etc. These substances are widely used in 
the fields of anti-cancer, anti-HIV, cosmetology, liver 
protection and flavoring. Direct extraction from natural 
plants is the main form of production of natural 
medicines from these plants today, and many of our 
well-known drugs are derived from this type of 
production. However, this production method directly 
extracted from the original plant has many shortcomings, 
such as, low drug content, large production difference, 
difficult product purification, long plant growth, and 
serious damage to natural resources, especially wild 
resources that cannot be planted. Nowadays, wild 
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precious Chinese herbal medicines such as ginseng and 
Ganoderma lucidum are endangered due to excessive 
utilization and destruction. Although some varieties can 
be supplemented by cultivation methods, due to the 
deterioration of varieties and other reasons, especially 
the problems of continuous cropping, the sustainability 
of resource utilization in China is facing great 
difficulties. Synthesizing corresponding active 
ingredient through biotechnology will become a new 




2 EXPERIMENTAL MATERIALS 
2.1 Cell line 
The bladder cancer T24 cell line, purchased from 




Reagent name Company 
Germacrene A (purity above 96%) Tianjin Institute of Industrial Biotechnology,     
Chinese Academy of Sciences 
0.25 Trypsin American Gibco 
EDTA Tianjin Dingshengxin Chemical Co., Ltd. 
DMSO Xingchang Chemical 
RPMI-1640 Medium American Gibco 
Fetal Bovine Serum (FBS) American Gibco 
PBS Zhejiang Hangzhou Xinfu Pharmaceutical Co., Ltd. 
Thiazole Blue (MTT) Shanghai Baili Biotechnology Co., Ltd. 
Dimethyl sulfoxide Sigma USA American Sigma 
0.4% trypan blue Beijing Aidelai cyclic peptide organism 
 
2.3 Main instruments 
Instrument Manufacturer 
Ultra-clean work bench Changsha Qiulong Instrument Equipment Co., Ltd. 
Thermostat cell incubator American Thermo 
Frozen Multi-Function Centrifuge American Beckman 
Electronic balance Shanghai Shenghui Electronics Co., Ltd. 
Inverted microscope Shanghai Zhongheng Instrument Co., Ltd. 
Microplate reader  American BIO-TEK company 
1000μL pipetting gun  Eppenddorf, Germany 
100μL pipetting gun Eppenddorf, Germany 
Water bath box  Shanghai Zhiyu Analytical Instrument Manufacturing Co., Ltd. 
Liquid nitrogen tank (East Asia brand liquid 
nitrogen container) 
Leshan East Asia Machine Electric Co., Ltd. 
UV disinfection vehicle (SNXIN)  Jiangsu Shenxing Optoelectronic Medical Equipment Co., Ltd. 
Electric thermostat blast drying oven 
(DHG-9075A) 
Shanghai Feiyue Experimental Instrument Co., Ltd. 
6-well sterile plate  American Costar 
96-well sterile culture plate BIOFIL 
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3 EXPERIMENTAL CONTENT 
3.1 Solution preparation 
3.1.1 Germacrene A solution 
The germacrene A solution was filtered using a 0.22 μm 
sterile filter. The solution density was adjusted to 10 
mmol/L with PBS buffer to prepare a gemalene A 
mother liquor. The prepared mother liquid was diluted 
stepwise with a serum-free medium to prepare a solution 
of gemasene A of 0.02, 0.01, and 0.008 mg/ml. Please 
use the drug solution right after it was ready. 
3.1.2 Preparation of PBS buffer 
Pour a packet of PBS into 2000 mL of ultrapure water. 
After it is fully dissolved, adjust the pH to 7.2 and 
dispense with a screw bottle to prevent contamination of 
the PBS in subsequent experiments and cause waste. 
Autoclave for 30 minutes, cool down to room 
temperature and store at 4 °C. 
3.1.3 Preparation of cell culture medium 
Take an appropriate amount of fetal bovine serum and 
medium, and arrange it in a ratio of 1:9. After mixing 
evenly, it is dispensed with a screw bottle to prevent 
contamination due to mistakes during the experimental 
operation, so that the culture solution is completely 
wasted. The preparation was completed and stored at 
4 °C, and it was rewarmed at 37 °C before use. 
3.1.4 Preparation of MTT (5mg/mL) 
Weigh accurately 0.5 g of MTT, dissolve it in 1000 mL 
of PBS buffer in the dark, mix well, and store at 4 °C. 
3.1.5 Preparation of 0.25% trypsin 
Weigh 0.25 g of trypsin, dissolve it in 100 mL of PBS 
buffer, stir at low speed, filter and dispense, store at 4 °C, 
and use it for a short time. 
3.1.6 Preparation of cell cryopreservation solution 
Take appropriate amount of DMSO and FBS, mix well 
in a ratio of 1:9, and use it after it is ready. 
3.2 Cell culture 
3.2.1 Cellular resuscitation 
The cryotube containing the cells was taken out and 
thawed at 37°C. After thawing thoroughly, the cell 
suspension was aspirated into a centrifuge tube, diluted 
with an appropriate amount of the culture solution and 
centrifuged (500 rpm, 3 min) in a centrifuge. Discard the 
supernatant and add an appropriate amount of the 
culture solution to the centrifuge tube until the cells are 
evenly distributed to prepare a suspension. The cell 
suspension was transferred to a culture flask, cultured in 
a 37°C, 5% CO 2 incubator, and the culture solution was 
changed in time during the culture. Pay attention to 
observe the cell growth under a microscope, and the 
cells need subculturing when they are grown to about 
80% to 95% of bottle bottom. 
3.2.2 Cell passaging 
Remove the flask from the incubator and tighten the cap 
during the procedure. Place the culture flask on the 
ultra-clean workbench, aspirate the culture solution, 
discard it, rinse it with appropriate amount of PBS 
buffer for 2~3 times and discard the PBS. Slowly add an 
appropriate amount of 0.05% trypsin solution along the 
cell-free side and digest at room temperature for about 1 
to 3 minutes. During the period, observe the cell 
morphology under the microscope. After the cells are 
completely digested, discard most of the trypsin and 
gently tap. The culture solution was added and pipetted 
into a single cell suspension. Transfer the suspension to 
the centrifuge tube and continue to blow. After pipetting 
evenly, count using a cell counting plate to adjust the 
concentration. The desired suspension is placed in a 
culture flask, and an appropriate amount of the culture 
solution is added, and the culture is continued in a 
constant temperature incubator. 
3.2.3 Cell cryopreservation 
The culture medium was aspirated, and the bladder 
cancer T24 cells in the logarithmic growth phase were 
digested with trypsin digestive solution containing 
EDTA, observed under a microscope, and after 
centrifugation was completed, centrifuged (1000 rpm, 5 
min), the supernatant was discarded, And add 
appropriate amount of frozen solution (containing 10% 
DMSO and 90% FBS), adjust the cell density to 1 × 10
6
 
~ 1 × 10
7
 / ml, blow evenly and dispense into the 
cryotube, put in 4°C 4h; -20°C 4h; -80°C 4h conditions, 
the temperature was lowered, and finally store the 
cryotube in a liquid nitrogen tank for storage. 
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3.3 Grouping 
Control group: only medium was added. 
Experimental group: The concentration of germacrene A 
was set to be 0.008 mg/ml, 0.01 mg/ml, and 0.02 mg/ml, 
respectively. 
Each of the above groups is provided with three 
duplicate holes. 
3.4 Experimental methods 
This study is based on obtaining germacrene A，which is 
the analogue of synthetic β-elemene, by means of 
synthetic biology, the following three detection methods 
were used to conduct experiments and investigate the 
effect of germacrene A on T24 bladder cancer cells: 
3.4.1 Observation of cell morphology changes by 
inverted microscope 
Human bladder cancer T24 cells in logarithmic growth 
phase were inoculated into 6-well cell culture plates and 
cultured in a 37 °C, 5% CO 2 incubator for 24 h. After 
the cells were attached, each group of drugs was added 
and cultured for 24 h, respectively. Morphological 
changes of human bladder cancer T24 cells were 
observed under a microscope. 
3.4.2 Trypan blue exclusion method to detect cell 
death 
Human bladder cancer T24 cells in logarithmic growth 
phase were inoculated into 6-well cell culture plates and 
cultured for 24 hours. The mice were divided into 
experimental group and control group. Different 
concentrations of germacrene A were added and cultured 
for 24 hours. The cells in the culture wells were 
collected and trypsinized to prepare a single cell 
suspension. Adjust the cell density appropriately and 
blow evenly. Take 0.5-1.0 ml of cell suspension into the 
centrifuge tube, add 0.4% trypan blue dye solution in 
equal amount, stain for 2-3 min, and add a small amount 
of cell suspension with a micropipette. Slides were used 
to observe cell staining. Dead cells can be stained by 
trypan blue, which can be seen as light blue cells under 
the microscope. Live cells cannot be stained, and the 
cells are colorless and transparent. 
3.4.3 MTT assay for the effect of germacrene A on 
cancer cell proliferation 
The log phase cells were seeded into 96-well plates, and 
the cells in the 96-well plates were cultured at constant 
temperature in a cell culture incubator. After adherence, 
different concentrations of germacrene A were added to 
the corresponding wells. 20 μL of the prepared MTT 
solution was added to each well after 24 hours and 48 
hours of drug action, respectively. After incubating for 4 
h at a constant temperature, the upper medium was 
discarded, 100 μL of DMSO was added, and shaken for 
10 min. The treated 96-well plates were examined using 
a microplate reader. The absorbance A value was 
measured at a wavelength of 490 nm. 
Cell proliferation inhibition rate (%) = (control hole OD 
value - drug hole OD value) / control hole OD value × 
100% 
The cell proliferation inhibition rate was calculated 
according to the above formula. 
4 EXPERIMENTAL RESULTS 
4.1 Cell morphology change results 
The changes in the morphology of human bladder 
transitional cell carcinoma T24 cells by germacrene A 
are shown in the figure below. In the control group, the 
cells were wedge-shaped or long fusiform, adherent to 
the wall and vigorous, with high cell density, uniform 
growth distribution, clear contour and visible cell 
membrane.. In the experimental group T24 cells treated 
with germacrene A, cell growth was inhibited and the 
number was significantly reduced. In the experimental 
group with increased concentration, the cell volume of 
the tumor cells was significantly reduced, the shape was 
gradually changed from a wedge shape to a polygonal 
shape, and the cells were soon fell off，atrophied and 
fragmented. There were many broken cell fragments in 
the medium. The greater the concentration of 
administration, the changes in cell morphology are more 
obvious and the number of survival cells is smaller.
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4.2 Tray blue rejection method results 
The membrane structure of normal living cells is intact, 
and they can repel the trypan blue; The membrane 
permeability of cells which lose their activity or 
incomplete cell membrane increases, and those cells can 
be dyed blue by trypan blue, So living cells and dead 
cells can be differentiate by trypan blue. Through the 
experimental results, it can be found that the number of 
cell staining of the tumor cells in the experimental group 
after the treatment with germacrene A was significantly 
increased. In the experimental group with increased 
concentration, the number of cells stained was higher, 
and only a few were colorless and transparent cells. The 
morphology of germacrene A in human bladder 
transitional cell carcinoma T24 cells was stained with 
trypan blue as shown in Figure 5-8.
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4.3 MTT test results 
After treatment with different concentrations of 
germacrene A, cell growth was inhibited to varying 
degrees, and this effect showed time and concentration 
dependence, as shown in Table 1 and Figure 9. At the 
same time, the inhibition rate increases with the increase 
of the concentration; at the same concentration, the 
inhibition rate increases with the increase of the action 
time.
Table 1: Effect of in vitro Germacrene A on cell growth inhibition 
Group concentration  OD value cell inhibition rate 
（%） 
 （mg/ml） 24h 48h 24h 48h 
Germacrene A 
group 
0.02 0.069±0.005 0.048±0.004 38.30 55.14 
0.01 0.090±0.004 0.073±0.003 19.64 31.77 
0.008 0.099±0.003 0.080±0.005 11.61 25.23 
Control group - 0.112±0.004 0.107±0.003 0 0 
 
 
5 EXPERIMENTAL DISCUSSION AND 
PROSPECTS 
T24 cells are wedge-shaped or long fusiform, adherent 
growth, T24 cells without drug treatment have strong 
growth, large cell density, uniform growth distribution, 
clear outline and clear cell membrane. After TMA cells 
treated with germacrene A, cell growth was inhibited, 
the number of cells was significantly reduced, and the 
cell volume was also significantly reduced. The shape 
was gradually changed from a wedge shape to a 
polygonal shape, as the action time lengthens, the 
phenomenons such as shedding, shrinkage, 
fragmentation begin to appear. And as the concentration 
of the drug is increased, the change in cell morphology 
is more obvious, and the number of cell survival is less, 
showing a certain gradient. 
Normal living cells, whose membrane structure are 
intact ,can repel the trypan blue, so that the trypan blue 
can not get inside the cells; While the cells that lose 
activity or incomplete cell membranecan be dyed blue 
by trypanblue because the permeability of the membrane 
increases, It can be considered that the cell has died 
when cell membrane lose integrity, and it has same 
effect on necrotic, So living cells and dead cells can be 
distinguished quickly and easily. 
Afer the T24 cells treated with germacrene A were 
stained with trypan blue, it can be found that the cells 
began to die and the cell density decreased when they 
are reacted with different concentrations of germacrene 
A. Compared with the viable cells, the dead cells were 
stained. Compared with the blank control group, the 
morphological effect of germacrene A on T24 cells was 
significant, and it became more and more significant 
with the increase of concentration. From this result, it 
can be seen that gemalene A has a significant effect on 
inhibiting bladder cancer T24 cells. 
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The principle of MTT assay is that succinate 
dehydrogenase in living cell mitochondria can reduce 
exogenous MTT to water-insoluble blue-purple crystal 
formamidine and deposit it in cells, while dead cells do 
not. Dimethyl sulfoxide can dissolve the 
hyperthyroidism in the cells, and its light absorption 
value is measured by a microplate reader at a 
wavelength of 490 nm. The amount of MTT crystal 
formation is proportional to the number of cells in a 
certain cell number range. The number of viable cells is 
judged based on the measured absorbance value. 
From the result of the experiment which detects the 
proliferation of germacrene A on T24 cells by the MTT 
assay, it can be found that after different concentrations 
of germacrene A, the growth of cells is affected to 
varying degrees. With the increase of drug concentration, 
the cell inhibition rate begins to rise; the action time is 
longer, the inhibition rate is higher. This inhibition of 
cancer cells exhibits a dependence on time and 
concentration. Germacrene A has a very significant 
effect in inhibiting the proliferation of bladder cancer 
T24 cells, especially under high dose treatment. The 
discovery of this phenomenon is conducive to the further 
study of germacrene A, which can provide a certain 
experimental basis for the clinical trial of germacrene A. 
From the above experimental results, it can be found that 
after different concentrations of germacrene A, cell 
growth was inhibited by different levels, and the 
inhibition was time-dependent and concentration- 
dependent. Germacrene A can inhibit the growth of 
cancer cells in a concentration-dependent manner, and 
high dose can significantly prevent the proliferation of 
cancer cells. The drug effects at different times also have 
different effects on tumor cells. These results 
demonstrate that germacrene A has a good performance 
in inhibiting tumor cell proliferation. This finding 
contributes to the experimental basis for further research 
and clinical trials of gemasene A. 
In summary, gemalene A has obvious curative effect on 
anti-tumor effect. The anti-tumor mechanism of 
germacrene A may be through induction of apoptosis, 
but a clearer mechanism remains to be explored. 
Nowadays, the anti-tumor mechanism of β-elemene, 
which has been put into clinical use, has been relatively 
mature, and it has made some progress in the research on 
the mechanism of anti-drug resistance 
13-14 
. Further 
investigation and research are needed on the study of 
resistance of germacrene A. 
Cancer is one of the leading causes of human death, and 
countless researchers are working on anti-tumor drugs. 
For the research of anti-tumor drugs, the road is still 
very long, and it is an inevitable trend to continuously 
explore new drugs. With the development of 
biotechnology, synthetic biology has become a green 
production method, which has important significance in 
the research of various natural medicines 
15
, and its 
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